SIGN IN

Harbor Health Care ETF (MEDI)

Built on a rich history of Health Care Investing

Welcome
Overview
Performance
Holdings
Investment Team
Documents

Overview

Current Price

as of 1/31/2023

NAV Price

$20.70

NAV Daily Change ($)

$0.33

NAV Daily Change (%)

1.62%

NAV YTD Return

2.27%

Market Price

$20.68

Market Daily Change ($)

$0.31

Market Daily Change (%)

1.52%

Market YTD Return

2.17%

Fund Facts

Inception Date

11/16/2022

Expense Ratio (%)

0.80%

Total Net Assets (million)
(As of 2/1/2023)

$3.623

Shares Outstanding
(As of 2/1/2023)

175,000

Ticker

MEDI

Cusip

41151J869

ISIN

US41151J896

Benchmark

Russell 3000® Growth Health Care Index

Exchange

NYSE

Distributor

Foreside Fund Services, LLC

Investment Objective

The Fund seeks long-term growth of capital.

Morningstar Category

Health

Dividend Frequency

Annually

Pricing/Trading

as of 1/31/2023

Bid/Ask Mid Price

$20.71

Closing Market Price

$20.68

Premium/Discount ($)

$0.00

Premium/Discount (%)

0.01%

 

2022

Q1 2023

YTD

Days Traded at a Premium301919
Days Traded at a Discount011
30-Day Median Bid/Ask Spread

0.30%

Exchange Volume (Shares)

30

Trading Currency

USD

Historical Premium Discount to NAV

2022
Q1 2023
left quote

"Health care is a sector that we are very passionate about, and one in which we have a strong history."

right quote

Matthew R. Renna

Partner, Portfolio Manager, Westfield Capital Management Company L.P.

Performance

Total Returns

MONTH-END
QUARTER-END
YEAR-BY-YEAR
MONTH-BY-MONTH

Fund Name

YTD Return

Since Inception

Net Expense Ratio

Gross Expense Ratio

Health Care ETF

2.27%

4.23%

0.80%

0.80%

Fund Market Price

2.17%

4.82%

--

--

Russell 3000 Growth Health Care Index

-0.63%

1.26%

--

--

Performance data shown represents past performance and is no guarantee of future results. Past performance is net of management fees and expenses and reflects reinvested dividends and distributions. Past performance reflects the beneficial effect of any expense waivers or reimbursements, without which returns would have been lower. Investment returns and principal value will fluctuate and when redeemed may be worth more or less than their original cost. Returns for periods less than one year are not annualized. Current performance may be higher or lower and is available through the most recent month end at harborcapital.com or by calling 800-422-1050.

The Russell 3000® Growth Health Care Index is an unmanaged index generally representative of companies involved in medical services or health care in the Russell 3000 Index, which is comprised of the 3,000 largest U.S. companies as determined by total market capitalization. This unmanaged index does not reflect fees and expenses and is not available for direct investment. Short term performance, in particular, is not a good indication of the fund's future performance, and an investment should not be made based solely on returns.

Price History

CHART
TABLE

Ex-Date

Record Date

Payable Date

Ordinary Income

Short Term Capital Gains

Long Term Capital Gains

Total Distribution

12/21/2022

12/22/2022

12/27/2022

--

--

--

0.00000

Holdings

Portfolio Characteristics

as of 12/31/2022

Health Care ETF

Number of Holdings

34

Wtd Avg Market Cap ($Mil)

146858.1

Price/Book Ratio

6.68

Adjusted Trailing P/E Ratio

31

% EPS Growth - Past 3 Yr

24.8

Return on Equity (%)

20.52

Forecasted P/E Ratio

24.1

Top Ten Holdings

as of 1/31/2023

Company Name [Ticker]

% of Net Assets

UNITEDHEALTH GROUP INC COMMON STOCK USD.01[UNH]

13.8

ELI LILLY + CO COMMON STOCK[LLY]

11.3

ASCENDIS PHARMA A/S ADR ADR DKK1.0[ASND]

8.7

ICON PLC COMMON STOCK EUR.06[ICLR]

6.2

ALKERMES PLC COMMON STOCK USD.01[ALKS]

4.9

THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0[TMO]

4.7

LANTHEUS HOLDINGS INC COMMON STOCK USD.01[LNTH]

4.6

BIO RAD LABORATORIES A COMMON STOCK USD.0001[BIO]

4.2

ABBVIE INC COMMON STOCK USD.01[ABBV]

3.8

DEXCOM INC COMMON STOCK USD.001[DXCM]

3.7

% of Total Holdings:

65.9%

This information should not be considered as a recommendation to purchase or sell a particular security. The holdings mentioned may change at any time and may not represent current or future investments.

as of 1/31/2023

Company Name [Ticker]

Category Name

Country

Cusip

Shares

Current Price ($)

Market Value ($)

% of Net Assets

UNITEDHEALTH GROUP INC COMMON STOCK USD.01 [UNH]

Equity

UNITED STATES

91324P102

1,001

499.19

499,689.19

13.8

ELI LILLY + CO COMMON STOCK [LLY]

Equity

UNITED STATES

532457108

1,190

344.15

409,538.50

11.3

ASCENDIS PHARMA A/S ADR ADR DKK1.0 [ASND]

Equity

DENMARK

04351P101

2,527

124.08

313,550.16

8.7

ICON PLC COMMON STOCK EUR.06 [ICLR]

Equity

IRELAND

G4705A100

966

230.71

222,865.86

6.2

ALKERMES PLC COMMON STOCK USD.01 [ALKS]

Equity

IRELAND

G01767105

6,213

28.64

177,940.32

4.9

THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0 [TMO]

Equity

UNITED STATES

883556102

299

570.33

170,528.67

4.7

LANTHEUS HOLDINGS INC COMMON STOCK USD.01 [LNTH]

Equity

UNITED STATES

516544103

2,868

57.50

164,910.00

4.6

BIO RAD LABORATORIES A COMMON STOCK USD.0001 [BIO]

Equity

UNITED STATES

090572207

329

467.46

153,794.34

4.2

ABBVIE INC COMMON STOCK USD.01 [ABBV]

Equity

UNITED STATES

00287Y109

930

147.75

137,407.50

3.8

DEXCOM INC COMMON STOCK USD.001 [DXCM]

Equity

UNITED STATES

252131107

1,238

107.09

132,577.42

3.7

MERCK + CO. INC. COMMON STOCK USD.5 [MRK]

Equity

UNITED STATES

58933Y105

1,130

107.41

121,373.30

3.4

CATALENT INC COMMON STOCK USD.01 [CTLT]

Equity

UNITED STATES

148806102

1,727

53.55

92,480.85

2.6

IDEXX LABORATORIES INC COMMON STOCK USD.1 [IDXX]

Equity

UNITED STATES

45168D104

173

480.50

83,126.50

2.3

SAREPTA THERAPEUTICS INC COMMON STOCK USD.0001 [SRPT]

Equity

UNITED STATES

803607100

665

124.97

83,105.05

2.3

AVANTOR INC COMMON STOCK USD.01 [AVTR]

Equity

UNITED STATES

05352A100

3,353

23.90

80,136.70

2.2

VERTEX PHARMACEUTICALS INC COMMON STOCK USD.01 [VRTX]

Equity

UNITED STATES

92532F100

239

323.10

77,220.90

2.1

AMEDISYS INC COMMON STOCK USD.001 [AMED]

Equity

UNITED STATES

023436108

777

96.66

75,104.82

2.1

INSULET CORP COMMON STOCK USD.001 [PODD]

Equity

UNITED STATES

45784P101

231

287.32

66,370.92

1.8

INSPIRE MEDICAL SYSTEMS INC COMMON STOCK USD.001 [INSP]

Equity

UNITED STATES

457730109

238

253.06

60,228.28

1.7

COOPER COS INC/THE COMMON STOCK USD.1 [COO]

Equity

UNITED STATES

216648402

167

348.93

58,271.31

1.6

VERADIGM INC COMMON STOCK USD.01 [MDRX]

Equity

UNITED STATES

01988P108

2,912

17.91

52,153.92

1.4

ROCKET PHARMACEUTICALS INC COMMON STOCK USD.01 [RCKT]

Equity

UNITED STATES

77313F106

2,261

21.73

49,131.53

1.4

PROMETHEUS BIOSCIENCES INC COMMON STOCK USD.0001 [RXDX]

Equity

UNITED STATES

74349U108

390

113.66

44,327.40

1.2

APELLIS PHARMACEUTICALS INC COMMON STOCK USD.0001 [APLS]

Equity

UNITED STATES

03753U106

777

52.73

40,971.21

1.1

HAEMONETICS CORP/MASS COMMON STOCK USD.01 [HAE]

Equity

UNITED STATES

405024100

447

84.60

37,816.20

1.0

OPTION CARE HEALTH INC COMMON STOCK USD.0001 [OPCH]

Equity

UNITED STATES

68404L201

1,169

28.87

33,749.03

0.9

SEAGEN INC COMMON STOCK USD.001 [SGEN]

Equity

UNITED STATES

81181C104

217

139.48

30,267.16

0.8

NEUROCRINE BIOSCIENCES INC COMMON STOCK USD.001 [NBIX]

Equity

UNITED STATES

64125C109

244

110.93

27,066.92

0.7

AZENTA INC COMMON STOCK USD.01 [AZTA]

Equity

UNITED STATES

114340102

427

55.90

23,869.30

0.7

KARUNA THERAPEUTICS INC COMMON STOCK USD.00001 [KRTX]

Equity

UNITED STATES

48576A100

97

199.39

19,340.83

0.5

BICYCLE THERAPEUTICS PLC ADR ADR USD.01 [BCYC]

Equity

UNITED KINGDOM

088786108

651

27.62

17,980.62

0.5

QUEST DIAGNOSTICS INC COMMON STOCK USD.01 [DGX]

Equity

UNITED STATES

74834L100

121

148.48

17,966.08

0.5

ARCUTIS BIOTHERAPEUTICS INC COMMON STOCK USD.0001 [ARQT]

Equity

UNITED STATES

03969K108

847

16.57

14,034.79

0.4

REPLIGEN CORP COMMON STOCK USD.01 [RGEN]

Equity

UNITED STATES

759916109

56

185.30

10,376.80

0.3

INNOVIVA INC COMMON STOCK USD.01 [INVA]

Equity

UNITED STATES

45781M101

662

12.65

8,374.30

0.2

Total

--

--

--

--

--

3,608

99.6

Cash and Other Assets Less Liabilities

--

--

--

--

--

--

0.4

Total Net Assets

--

--

--

--

--

--

100%

Sorry, there is no data available for this fund

Sorry, there is no data available for this fund

Investment Team

Westfield Management Company, L.P.


Westfield Capital Management Company, L.P. is dedicated to providing strong and consistent investment performance based on a disciplined, team-based approach, with exceptional client service. Westfield believes their greatest strength comes from the collective wisdom of a fully engaged and inspired team working together with clear objectives. Additionally, Westfield embraces their partnership structure, which aligns the advancement of the organization with their clients and serves to attract and retain exceptional talent.

Investing involves risk, principal loss is possible. Unlike mutual funds, ETFs may trade at a premium or discount to their net asset value. Harbor ETFs are new and have limited operating history to judge.

There is no guarantee that the investment objective of the Fund will be achieved.  Stock markets are volatile and equity values can decline significantly in response to adverse issuer, political, regulatory, market and economic conditions. Since the Fund may hold foreign securities, it may be subject to greater risks than funds invested only in the U.S. These risks are more severe for securities of issuers in emerging market regions. Foreign currencies can decline in value and can adversely affect the dollar value of the fund. Since the Fund typically invests in a limited number of companies, an adverse event affecting a particular company may hurt the Fund's performance more than if it had invested in a larger number of companies.  Authorized Participant Concentration/Trading Risk: Only authorized participants (“APs”) may engage in creation or redemption transactions directly with the Fund. The Fund is classified as non-diversified, a non-diversified Fund may invest a greater percentage of its assets in securities of a single issuer, and/or invest in a relatively small number of issuers, it is more susceptible to risks associated with a single economic, political or regulatory occurrence than a more diversified portfolio. New Fund Risk: There can be no assurance that the Fund will grow to or maintain an economically viable size, in which case the Board of Trustees may determine to liquidate the Fund. Small and Mid Cap Risk: The Fund’s performance may be more volatile because it may invest in issuers that are smaller companies.

Shares are bought and sold at market price not net asset value (NAV). Market price returns are based upon the closing composite market price and do not represent the returns you would receive if you traded shares at other times.

Weighted Average Market Capitalization: The average size of the companies in a portfolio or index as measured by the market value of outstanding shares.

Price/Book: The price-to-book (P/B) ratio evaluates a firm's market value relative to its book value.

Adjusted Trailing P/E Ratio: The Adjusted Trailing P/E (Price/Earnings) Ratio is the closing stock price divided by the sum of the last 12 months actual EPS.

% EPS Growth – Past 3 year: Earnings per share refers to the bottom-line measure of a company’s profitability defined as net income divided by the number of outstanding shares.

Return on Equity: Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders' equity.

Forecasted P/E Ratio: a measure of the P/E (price-to-earnings) ratio using forecasted earnings for the P/E calculation.

Projected Earnings Growth Rate: The expected EPS growth over the next 3-5 years calculated by FactSet from data provided by brokers.

2587304

Blue Background

Connect with us |

Harbor Funds Distributors, Inc. is the Distributor of the Harbor Mutual Funds.
Foreside Fund Services, LLC is the Distributor of the Harbor ETFs.

Investing involves risk and the potential loss of capital.

Investors should carefully consider the investment objectives, risks, charges and expenses of a fund before investing. To obtain a summary prospectus or prospectus for this and other information, click here or call 800-422-1050. Read it carefully before investing.

All trademarks or product names mentioned herein are the property of their respective owners. Copyright © 2023 Harbor Capital Advisors, Inc. All rights reserved.